ACTIVE

Dr. H. DE SAMBLANX, Inwendige Geneeskunde

Financial year 2025 · Closed on 31/12/2025

Net result193,5 k €+9,3 %over 1 year
Gross margin279,2 k €+8,0 %over 1 year
Equity845,3 k €+16,8 %over 1 year

Identity

Source · BCE/KBO

Dr. H. DE SAMBLANX, Inwendige Geneeskunde is a Private limited company incorporated in 2005. Its registered office is in Herentals.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0874.469.450
Incorporation
15/06/2005
Legal form
Private limited company
Registered office
Rode-Leeuwstraat(MRH) 23
2200 Herentals · FlandreSee on map
Contributed capital
12 500,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 21 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin279,2 k €258,6 k €170,1 k €178,1 k €177,7 k €
EBITDA279 k €258 k €169,7 k €177,3 k €177 k €
Operating result268 k €247,2 k €158,9 k €175,9 k €170 k €
Net result193,5 k €177,1 k €113,9 k €124,4 k €120 k €
Balance sheet
Equity845,3 k €723,6 k €638 k €602,5 k €556,1 k €
Total assets904,1 k €757,4 k €649,5 k €603,7 k €578,3 k €
Cash560,1 k €277,5 k €164,7 k €299,8 k €374,6 k €
Debts58,9 k €33,9 k €11,5 k €1,2 k €22,2 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

Hadewijch De Samblanx

Director · since 15 juin 2005

Active

Ended mandates

Hadewijch De Samblanx

Director

Ended
Hadewijch De Samblanx

Manager

Ended
Hadewijh De Samblanx

Manager

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date28/08/202629/08/202530/08/202401/09/202330/08/202230/08/2021
General meeting26/05/202626/05/202527/05/202429/05/202330/05/202231/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202526/05/202628/08/2026DutchPDF
Micro model31/12/202426/05/202529/08/2025DutchPDF
Abridged model31/12/202327/05/202430/08/2024DutchPDF
Abridged model31/12/202229/05/202301/09/2023DutchPDF
Abridged model31/12/202130/05/202230/08/2022DutchPDF
Abridged model31/12/202031/05/202130/08/2021DutchPDF
Abridged model31/12/201925/05/202028/08/2020DutchPDF
Abridged model31/12/201827/05/201930/08/2019DutchPDF
Abridged model31/12/201728/05/201830/08/2018DutchPDF
Abridged model31/12/201629/05/201731/08/2017DutchPDF
Abridged model31/12/201530/05/201626/08/2016DutchPDF
Abridged model31/12/201425/05/201531/08/2015DutchPDF
Abridged model31/12/201331/05/201429/08/2014DutchPDF
Abridged model31/12/201227/05/201330/08/2013DutchPDF
Abridged model31/12/201129/05/201229/08/2012DutchPDF
Abridged model31/12/201030/05/201112/08/2011DutchPDF
Abridged model31/12/200925/05/201029/07/2010DutchPDF
Abridged modelCorrection31/12/200825/05/200904/09/2009DutchPDF
Abridged model31/12/200825/05/200931/07/2009DutchPDF
Abridged model31/12/200726/05/200801/08/2008DutchPDF
Abridged model31/12/200628/05/200728/08/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 3 ended

Active mandates

Hadewijch De Samblanx

Director · since 15 juin 2005

Active

Ended mandates

Hadewijch De Samblanx

Director

Ended
Hadewijch De Samblanx

Manager

Ended
Hadewijh De Samblanx

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates04/10/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office11/08/2010
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other23/06/2005
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025193,5 k €↑
  2. 2024
    Annual accounts 2024177,1 k €↑
  3. 2024
    Name changeDr. H. DE SAMBLANX, Inwendige Geneeskunde
  4. 2023
    Annual accounts 2023113,9 k €↓
  5. 2022
    Annual accounts 2022124,4 k €↑
  6. 2021
    Annual accounts 2021120 k €↑
  7. 2021
    Name changeDr H De Samblanx , Inwendige Geneeskundige
  8. 2020
    Annual accounts 2020102 k €↑
  9. 2019
    Annual accounts 201971,8 k €↓
  10. 2018
    Annual accounts 201891,5 k €↑
  11. 2017
    Annual accounts 201778,4 k €↑
  12. 2016
    Annual accounts 201678 k €↓
  13. 2015
    Annual accounts 201579,9 k €↑
  14. 2014
    Annual accounts 201474,6 k €↓
  15. 2013
    Annual accounts 201392,4 k €↓
  16. 2012
    Annual accounts 2012100 k €↓
  17. 2011
    Annual accounts 2011102,3 k €↑
  18. 2010
    Annual accounts 201088,9 k €↑
  19. 2009
    Annual accounts 200920 k €↓
  20. 2008
    Annual accounts 200888,4 k €↑
  21. 2007
    Annual accounts 2007-12,9 k €↓
  22. 2006
    Annual accounts 2006142,4 k €
  23. 15/06/2005
    IncorporationPrivate limited company